Non-disclosure of drug injection practices as a barrier to HCV testing: results from the PrebupIV community-based research study
Abstract Background Hepatitis C virus (HCV) infection prevalence is particularly high in people who inject drugs (PWID), a population that faces many barriers to HCV testing and care.A better understanding of the determinants of access to HCV testing is needed to improve their engagement in the HCV care cascade.We used data from a cross-sectional s